1. Home
  2. SHOT vs INKT Comparison

SHOT vs INKT Comparison

Compare SHOT & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHOT
  • INKT
  • Stock Information
  • Founded
  • SHOT 2018
  • INKT 2017
  • Country
  • SHOT United States
  • INKT United States
  • Employees
  • SHOT N/A
  • INKT N/A
  • Industry
  • SHOT Biotechnology: Pharmaceutical Preparations
  • INKT Medicinal Chemicals and Botanical Products
  • Sector
  • SHOT Health Care
  • INKT Health Care
  • Exchange
  • SHOT Nasdaq
  • INKT Nasdaq
  • Market Cap
  • SHOT 31.4M
  • INKT 36.7M
  • IPO Year
  • SHOT 2020
  • INKT 2021
  • Fundamental
  • Price
  • SHOT $0.49
  • INKT $9.50
  • Analyst Decision
  • SHOT
  • INKT Strong Buy
  • Analyst Count
  • SHOT 0
  • INKT 2
  • Target Price
  • SHOT N/A
  • INKT $6.50
  • AVG Volume (30 Days)
  • SHOT 690.0K
  • INKT 72.8K
  • Earning Date
  • SHOT 03-31-2025
  • INKT 03-20-2025
  • Dividend Yield
  • SHOT N/A
  • INKT N/A
  • EPS Growth
  • SHOT N/A
  • INKT N/A
  • EPS
  • SHOT N/A
  • INKT N/A
  • Revenue
  • SHOT $652,495.00
  • INKT N/A
  • Revenue This Year
  • SHOT N/A
  • INKT N/A
  • Revenue Next Year
  • SHOT N/A
  • INKT N/A
  • P/E Ratio
  • SHOT N/A
  • INKT N/A
  • Revenue Growth
  • SHOT 68.01
  • INKT N/A
  • 52 Week Low
  • SHOT $0.45
  • INKT $4.56
  • 52 Week High
  • SHOT $2.89
  • INKT $19.00
  • Technical
  • Relative Strength Index (RSI)
  • SHOT 41.03
  • INKT 52.27
  • Support Level
  • SHOT $0.46
  • INKT $8.85
  • Resistance Level
  • SHOT $0.48
  • INKT $13.79
  • Average True Range (ATR)
  • SHOT 0.04
  • INKT 1.93
  • MACD
  • SHOT 0.01
  • INKT -0.07
  • Stochastic Oscillator
  • SHOT 28.35
  • INKT 53.50

About SHOT Safety Shot Inc.

Safety Shot Inc is a wellness and functional beverage company. It is set to launch Safety Shot, the patented beverage that helps people feel faster by reducing blood alcohol content and boosting clarity.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.

Share on Social Networks: